Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodyspplastic syndromes M. ImamuraS. KobayashiI. Maekawa Original Article Pages: 163 - 166
Induction of soluble IL-2 receptor in patients with myelodysplastic syndromes undergoing high-dose interleukin-3 treatment G. SeipeltA. GanserD. Hoelzer Original Article Pages: 167 - 170
Detection of allelic loss within the β1-interferon gene in childhood acute lymphoblastic leukemia using differential PCR C. A. SchmidtA. NeubauerW. Siegert Original Article Pages: 171 - 174
Cell cycle kinetics of hematopoiesis before and after in vivo administration of GM-CSF in refractory anemia: Evidence for a shortening of the granulocyte release time P. P. T. BronsN. Van Der LelyT. J. M. de Witte Original Article Pages: 175 - 181
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity D. PrzepiorkaM. DimopoulosR. E. Champlin Original Article Pages: 183 - 188
Evaluation of mixed chimerism by two-step polymerase chain reaction amplification of hypervariable region MCT118 after allogeneic bone marrow transplantation J. TanakaM. KasaiT. Miyazaki Original Article Pages: 189 - 193
Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide C. MrowkaG. H. ThoenesR. R. Bartlett Original Article Pages: 195 - 199
Postrenal transplant erythrocytosis: Further evidence implicating erythropoietin production by the native kidneys R. MartinoA. OliverA. F. Remacha Original Article Pages: 201 - 203
Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival S. RupoliL. Da LioP. Leoni Original Article Pages: 205 - 212
Polymyositis associated with chronic myelogenous leukemia L. C. PagliaroP. Mancias Case Report Pages: 213 - 214